Clinical Evaluation of CARESTREAM Vue PACS v12.2 MR Perfusion and Diffusion

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

68 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-07

Study Completion Date

2017-01-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to compare the diagnostic value of MR DSC-Perfusion (Perfusion Module), MR DWI (Diffusion Module) and MR DTI (Diffusion Module) in CARESTREAM Vue PACS ("investigational device") to the Olea Sphere PACS with Perfusion and DWI Modules ("predicate device"). Therefore, there will be several separate objectives depending on the type of acquisition:

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Refinement and Assessment of New MRI Technologies for Thoracic/ Cardiovascular Exams

NCT00727792

Magnetic Resonance Imaging (MRI) of the Chest

COMPLETED NA

Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue

NCT00723463

Brain Cancer Neck Cancer

COMPLETED EARLY_PHASE1

Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging

NCT03078192

Pulmonary Vascular Disease

COMPLETED PHASE2

Research on Infarction With Open Arteries Using OCT and CMR

NCT02270359

Myocardial Infarction

ACTIVE_NOT_RECRUITING NA

Evaluate the Effectiveness and Cost of Stress Cardiac Magnetic Resonance Imaging (MRI) for Non-invasive Evaluation of Lesions Discovered on Computed Tomography Angiography (CCTA)

NCT00538460

Coronary Disease

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Carestream Health, Inc. will investigate the imaging performance of the CARESTREAM Vue PACS v12.2 Magnetic Resonance (MR) Perfusion and Diffusion Weighted Imaging ("investigational device") performance. Evaluation of MR Dynamic Susceptibility Contrast-Enhanced Perfusion Weighted Imaging (DSC-Perfusion), MR Diffusion Weighted Imaging (DWI) and MR Diffusion Tensor Imaging (DTI) was compared to the predicate device, the Olea Sphere PACS with Perfusion and DWI Modules. MR DSC-Perfusion of the brain is a method for evaluating blood flow in the brain and producing optimized parametric maps that help visualize this blood flow. MR DWI is a method to evaluate the motion of water molecules within bodily tissues. MR DTI is an extension of DWI that allows extraction of the diffusion tensor. The purpose of this study is to demonstrate equivalent clinical quality between the investigational and predicate devices using a radiologist evaluation of key metrics which are applicable to MR DSC-Perfusion, MR DWI, and MR DTI images.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Predicate software

Olea Sphere PACS with Perfusion and DWI Modules

No interventions assigned to this group

Investigational software

Vue PACS v12.2 Magnetic Resonance (MR) Perfusion and Diffusion Weighted Imaging

Investigational software

Intervention Type DEVICE

The study evaluated retrospective de-identified cases that were processed after the imaging procedure had been completed (off-line) using a dedicated workstation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Investigational software

The study evaluated retrospective de-identified cases that were processed after the imaging procedure had been completed (off-line) using a dedicated workstation.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Retrospective patient MR DSC-Perfusion cases with subject/patient 18 years of age or older.
* Retrospective patient MR DWI with subject/patient 18 years of age or older.
* Retrospective patient MR DTI cases with subject/patient 18 years of age or older.
* Informed consent is not required if waiver of consent is approved by the hospital IRB/Ethics Committee

Exclusion Criteria

* Low quality images, or images that are not clinically acceptable for clinical diagnostic reading as determined by the Principal Investigator
* Subject less than 18 years of age

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No